Skip to main content
PMC home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1978 Mar;71(3):195–198. doi: 10.1177/014107687807100308

Recent advances in cytotoxic therapy for gastrointestinal carcinoma: a review.

T J Priestman
PMCID: PMC1436129  PMID: 633274

Full text

PDF
197

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnott S. J. The value of combined 5-fluorouracil and x-ray therapy in the palliation of locally recurrent and inoperable rectal carcinoma. Clin Radiol. 1975 Apr;26(2):177–182. doi: 10.1016/s0009-9260(75)80037-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cedermark B. J., Didolkar M. S., Elias E. G. Methyl-CCNU (NSC-95441) in advanced colorectal carcinoma after failure of 5-fluorouracil (NSC-19893) therapy. Cancer Treat Rep. 1976 Mar;60(3):235–238. [PubMed] [Google Scholar]
  3. Falkson G., van Eden E. B., Falkson H. C. Fluorouracil, imidazole carboxamide dimethyl triazeno, vincristine, and bis-chloroethyl nitrosourea in colon cancer. Cancer. 1974 May;33(5):1207–1209. doi: 10.1002/1097-0142(197405)33:5<1207::aid-cncr2820330502>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  4. Frytak S., Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Adriamycin (NSC-123127) therapy for advanced gastrointestinal cancer. Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):405–409. [PubMed] [Google Scholar]
  5. Giles G. R., Hall R., Brennan T. G., Worthy T. S. A trial of 1-(2-chlorethyl)-3-(4-methyl-cyclohexyl)-1-nitrosourea in the treatment of patients with advanced gastro-intestinal cancer. Br J Surg. 1974 Dec;61(12):950–950. doi: 10.1002/bjs.1800611206. [DOI] [PubMed] [Google Scholar]
  6. Kolarić K., Maricić Z., Dujmović I., Roth A. Therapy of advanced esophageal cancer with bleomycin, irradiation and combination of bleomycin with irradiation. Tumori. 1976 May-Jun;62(3):255–262. doi: 10.1177/030089167606200302. [DOI] [PubMed] [Google Scholar]
  7. Lawrence W., Jr, Terz J. J., Horsley S., 3rd, Donaldson M., Lovett W. L., Brown P. W., Ruffner B. W., Regelson W. Chemotherapy as an adjuvant to surgery for colorectal cancer. Ann Surg. 1975 May;181(5):616–623. doi: 10.1097/00000658-197505000-00016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Li M. C., Ross S. T. Chemoprophylaxis for patients with colorectal cancer. Prospective study with five-year follow-up. JAMA. 1976 Jun 28;235(26):2825–2828. [PubMed] [Google Scholar]
  9. Mackman S., Ansfield F. J., Ramirez G., Curreri A. R. A second look at the second operation in colonic cancer after the administration of fluorouracil. Am J Surg. 1974 Dec;128(6):763–766. doi: 10.1016/0002-9610(74)90066-x. [DOI] [PubMed] [Google Scholar]
  10. Marciniak T. A., Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Phase II study of ICRF-159 (NSC-129943) in advanced colorectal carcinoma. Cancer Chemother Rep. 1975 Jul-Aug;59(4):761–763. [PubMed] [Google Scholar]
  11. Mavligit G. M., Gutterman J. U., Burgess M. A., Khankhanian N., Seibert G. B., Speer J. F., Jubert A. V., Martin R. C., McBride C. M., Copeland E. M. Prolongation of postoperative disease-free interval and survival in human colorectal cancer by B.C.G. or B.C.G. plus 5-fluorouracil. Lancet. 1976 Apr 24;1(7965):871–876. doi: 10.1016/s0140-6736(76)92093-6. [DOI] [PubMed] [Google Scholar]
  12. Moertel C. G., Childs D. S., Jr, Reitemeier R. J., Colby M. Y., Jr, Holbrook M. A. Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 1969 Oct 25;2(7626):865–867. doi: 10.1016/s0140-6736(69)92326-5. [DOI] [PubMed] [Google Scholar]
  13. Moertel C. G. Clinical management of advanced gastrointestinal cancer. Cancer. 1975 Aug;36(2):675–682. doi: 10.1002/1097-0142(197508)36:2+<675::aid-cncr2820360810>3.0.co;2-a. [DOI] [PubMed] [Google Scholar]
  14. Moertel C. G., Schutt A. J., Hahn R. G., Marciniak T. A., Reitemeier R. J. Phase II study of chromomycin A3 (NSC-58514) in advanced colorectal carcinoma. Cancer Chemother Rep. 1975 May-Jun;59(3):577–579. [PubMed] [Google Scholar]
  15. Moertel C. G., Schutt A. J., Hahn R. G., Marciniak T. A., Reitemeier R. J. Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma. Cancer Chemother Rep. 1975 May-Jun;59(3):581–583. [PubMed] [Google Scholar]
  16. Moertel C. G., Schutt A. J., Hahn R. G., Reitemeier R. J. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine. J Natl Cancer Inst. 1975 Jan;54(1):69–71. doi: 10.1093/jnci/54.1.69. [DOI] [PubMed] [Google Scholar]
  17. Prostman T. J. Progress report. Cytotoxic therapy for gastrointestinal carcinoma. Gut. 1976 Apr;17(4):313–322. doi: 10.1136/gut.17.4.313. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES